Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544816 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of Snack Products on Energy
A NA study of Energy, sponsored by Mondelēz International.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT01544816: Completed NA study of Energy, sponsored by Mondelēz International.
NCT01544816 is a NA study of Energy that has completed, run by Mondelēz International. The registered enrollment target is 49 participants, below the 858-participant average among 7 other Energy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01544816, a NA study of Energy, has completed, sponsored by Mondelēz International.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effect of snack products varying in composition, on energy in healthy adult subjects.
Conditions Studied
Interventions
- OTHER Snack Product
Study Locations (1)
Georgia
- Mercer University Center for Clinical Research - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT01544816 record still lists
NCT01544816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 858-participant average among 7 other Energy trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Energy appearing as the primary indexed condition, and to 1 intervention - of which Snack Product is the first listed.
NCT01544816 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01544816 about?
NCT01544816 is a clinical study titled "Evaluating the Effects of Snack Products on Energy". To determine the effect of snack products varying in composition, on energy in healthy adult subjects.
What is the current status of trial NCT01544816?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2012-02. Estimated completion is 2012-08.
What conditions does trial NCT01544816 study?
This clinical trial studies the following conditions: Energy.
What interventions are being tested in trial NCT01544816?
The interventions under investigation include: Snack Product (OTHER).
Who is sponsoring clinical trial NCT01544816?
This trial is sponsored by Mondelēz International, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01544816 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Energy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels
RECRUITING · NA
-
Effects of Dynamine Ingestion on Various Indices of Sustained Energy
COMPLETED · NA
-
Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes
COMPLETED · NA
-
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
COMPLETED · NA
-
Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus
COMPLETED · NA
-
Alii Supplement Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia